BlackRock Investment Management, LLC - TRANSCEPT PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$6,0000.0%3,0410.0%0.00%
Q2 2014$6,0003,0410.00%
Other shareholders
TRANSCEPT PHARMACEUTICALS IN shareholders Q4 2014
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 1,942,184$3,865,0004.53%
NEA Management Company, LLC 2,086,755$4,153,0000.20%
BVF INC/IL 150,000$299,0000.05%
ABNER HERRMAN & BROCK LLC 20,000$40,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 137,000$273,0000.01%
Spark Investment Management LLC 16,100$32,0000.01%
CSS LLC/IL 20,420$41,0000.00%
Waverly Advisors, LLC 2,670$5,0000.00%
PANAGORA ASSET MANAGEMENT INC 134,293$267,0000.00%
DIMENSIONAL FUND ADVISORS LP 466,573$928,0000.00%
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders